NeuroPace, Inc.
NASDAQ:NPCE
7.14 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -32.956 | -47.082 | -36.08 | -24.278 | -29.973 |
| Depreciation & Amortization
| 1.605 | 2.987 | 0.296 | 0.312 | 0.421 |
| Deferred Income Tax
| 4.414 | 0 | 5.478 | 0.187 | -0.944 |
| Stock Based Compensation
| 9.558 | 8.349 | 4.288 | 1.379 | 1.442 |
| Change In Working Capital
| -2.484 | -4.788 | 0.368 | -2.067 | 0.009 |
| Accounts Receivables
| -4.85 | -0.391 | 1.304 | -2.378 | -0.75 |
| Inventory
| -1.698 | -2.133 | -1.156 | 0.672 | -1.638 |
| Accounts Payables
| 0.24 | 0.647 | 0.479 | -0.005 | -0.082 |
| Other Working Capital
| 3.824 | -2.911 | -0.259 | -0.356 | 2.479 |
| Other Non Cash Items
| 0.162 | 3.665 | 1.073 | 2.858 | 4.019 |
| Operating Cash Flow
| -19.701 | -36.869 | -24.577 | -21.609 | -25.026 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.173 | -0.603 | -0.384 | -0.062 | -0.468 |
| Acquisitions Net
| 0 | 0 | 0 | 10.705 | 0.004 |
| Purchases Of Investments
| 0 | 0 | -85.012 | -17.005 | -18.018 |
| Sales Maturities Of Investments
| 23.2 | 24.4 | 0 | 6.3 | 22.1 |
| Other Investing Activites
| 23.2 | 24.4 | -85.012 | -10.705 | 4.086 |
| Investing Cash Flow
| 23.027 | 23.797 | -85.396 | -10.767 | 3.618 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 8.386 | 0.896 | 109.089 | 31.497 | 0.042 |
| Common Stock Repurchased
| -0.259 | -0.059 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.259 | -0.347 | -2.473 | 65.632 | 42.656 |
| Financing Cash Flow
| 8.127 | 0.49 | 102.526 | 55.009 | 21.37 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 11.453 | -12.582 | -7.447 | 22.633 | -0.038 |
| Cash At End Of Period
| 18.058 | 6.727 | 19.309 | 26.756 | 4.123 |